D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 101 Citations 32,469 400 World Ranking 3624 National Ranking 2038

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Chemotherapy

Tracy T. Batchelor mainly investigates Internal medicine, Pathology, Cancer research, Surgery and Oncology. As part of his studies on Internal medicine, Tracy T. Batchelor often connects relevant subjects like Brain tumor. The concepts of his Pathology study are interwoven with issues in Tumor microenvironment, Microarray analysis techniques, Vascular endothelial growth factor A and Gene expression profiling.

He works on Cancer research which deals in particular with Glioma. Tracy T. Batchelor works mostly in the field of Surgery, limiting it down to topics relating to Lymphoma and, in certain cases, Malignancy, Biopsy and CSF albumin, as a part of the same area of interest. His Oncology research includes elements of Glioblastoma, Clinical trial, Immunology and Dacarbazine.

His most cited work include:

  • AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients (1520 citations)
  • Angiogenesis in brain tumours (995 citations)
  • Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. (823 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Oncology, Cancer research, Pathology and Glioma. His Internal medicine research focuses on Surgery and how it connects with Gastroenterology. His studies in Oncology integrate themes in fields like Cancer, Clinical trial, Phases of clinical research, Cediranib and Glioblastoma.

He has researched Cancer research in several fields, including Recurrent glioblastoma and In vivo. Tracy T. Batchelor has included themes like Magnetic resonance imaging, Angiogenesis and Perfusion in his Pathology study. His Glioma study also includes fields such as

  • Bevacizumab which connect with Vascular endothelial growth factor,
  • Pharmacology which connect with Toxicity.

He most often published in these fields:

  • Internal medicine (40.41%)
  • Oncology (31.37%)
  • Cancer research (22.51%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (22.51%)
  • Internal medicine (40.41%)
  • Glioma (20.85%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cancer research, Internal medicine, Glioma, Oncology and Temozolomide. Tracy T. Batchelor combines subjects such as Exome sequencing, Cancer, Primary central nervous system lymphoma, Kinase and In vivo with his study of Cancer research. In his papers, Tracy T. Batchelor integrates diverse fields, such as Internal medicine and In patient.

The various areas that Tracy T. Batchelor examines in his Glioma study include Isocitrate dehydrogenase, Thalamus, Mutant, Fluid-attenuated inversion recovery and Brain tumor. His Oncology study integrates concerns from other disciplines, such as Bevacizumab, Chemotherapy, Toxicity, Radiation therapy and Glioblastoma. His Radiation therapy research includes themes of Disease and Lymphoma.

Between 2017 and 2021, his most popular works were:

  • An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma (341 citations)
  • Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq (206 citations)
  • cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant (123 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

His primary areas of investigation include Cancer research, Internal medicine, Glioma, Oncology and Temozolomide. The study incorporates disciplines such as Exome sequencing, Mutation, Primary central nervous system lymphoma, Kinase and In vivo in addition to Cancer research. As part of his studies on Internal medicine, he often connects relevant areas like Radiography.

His research in Glioma focuses on subjects like Isocitrate dehydrogenase, which are connected to IDH1 and Mutant. His studies deal with areas such as Clinical trial, Toxicity, Bevacizumab, Radiation therapy and Glioblastoma as well as Oncology. His Temozolomide research is multidisciplinary, incorporating elements of T cell, Cancer and DNA mismatch repair.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Tracy T. Batchelor;A. Gregory Sorensen;A. Gregory Sorensen;Emmanuelle di Tomaso;Wei Ting Zhang;Wei Ting Zhang.
Cancer Cell (2007)

1943 Citations

Angiogenesis in brain tumours

Rakesh K. Jain;Emmanuelle di Tomaso;Dan G. Duda;Jay S. Loeffler.
Nature Reviews Neuroscience (2007)

1319 Citations

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

Catherine L. Nutt;D. R. Mani;Rebecca A. Betensky;Pablo Tamayo.
Cancer Research (2003)

1084 Citations

Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz.
Journal of Clinical Oncology (2005)

645 Citations

Biomarkers of response and resistance to antiangiogenic therapy.

Rakesh K. Jain;Dan G. Duda;Christopher G. Willett;Dushyant V. Sahani.
Nature Reviews Clinical Oncology (2009)

614 Citations

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

Priscilla K. Brastianos;Scott L. Carter;Scott L. Carter;Sandro Santagata;Sandro Santagata;Daniel P. Cahill.
Cancer Discovery (2015)

574 Citations

Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07

Tracy Batchelor;Kathryn Carson;Alison O’Neill;Stuart A. Grossman.
Journal of Clinical Oncology (2003)

553 Citations

Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

Tracy T. Batchelor;Dan G. Duda;Emmanuelle di Tomaso;Marek Ancukiewicz.
Journal of Clinical Oncology (2010)

498 Citations

Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

Michael J. Glantz;Suzanne LaFollette;Kurt A. Jaeckle;William Shapiro.
Journal of Clinical Oncology (1999)

449 Citations

Primary CNS Lymphoma

Tracy Batchelor;Jay S. Loeffler.
Journal of Clinical Oncology (2006)

439 Citations

Best Scientists Citing Tracy T. Batchelor

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 217

Michael Weller

Michael Weller

University of Zurich

Publications: 161

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 157

Rakesh K. Jain

Rakesh K. Jain

Harvard University

Publications: 123

David A. Reardon

David A. Reardon

Harvard University

Publications: 121

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 109

Lisa M. DeAngelis

Lisa M. DeAngelis

Memorial Sloan Kettering Cancer Center

Publications: 103

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 95

Mark R. Gilbert

Mark R. Gilbert

The University of Texas MD Anderson Cancer Center

Publications: 87

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 85

Marc C. Chamberlain

Marc C. Chamberlain

University of Washington

Publications: 85

Keith L. Ligon

Keith L. Ligon

Harvard University

Publications: 82

Susan M. Chang

Susan M. Chang

University of California, San Francisco

Publications: 79

Khê Hoang-Xuan

Khê Hoang-Xuan

Université Paris Cité

Publications: 71

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 69

Roger Stupp

Roger Stupp

Northwestern University

Publications: 65

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.